StockNews.com Upgrades DENTSPLY SIRONA (NASDAQ:XRAY) to Buy

DENTSPLY SIRONA (NASDAQ:XRAY) was upgraded by research analysts at StockNews.com from a “hold” rating to a “buy” rating in a report issued on Tuesday.

A number of other research analysts have also recently commented on XRAY. Robert W. Baird decreased their price target on DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating on the stock in a research note on Friday, November 8th. UBS Group lowered their target price on DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating for the company in a report on Tuesday, December 3rd. Needham & Company LLC reaffirmed a “buy” rating and issued a $25.00 target price on shares of DENTSPLY SIRONA in a research report on Tuesday, February 11th. Mizuho assumed coverage on shares of DENTSPLY SIRONA in a research report on Wednesday, December 4th. They set a “neutral” rating and a $21.00 price target on the stock. Finally, Jefferies Financial Group cut shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating and dropped their price objective for the company from $30.00 to $20.00 in a report on Thursday, January 23rd. Ten analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $25.85.

DENTSPLY SIRONA Price Performance

DENTSPLY SIRONA stock opened at $18.98 on Tuesday. The company’s 50 day simple moving average is $18.96 and its 200-day simple moving average is $21.77. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. DENTSPLY SIRONA has a 1 year low of $17.21 and a 1 year high of $34.91. The company has a market capitalization of $3.77 billion, a price-to-earnings ratio of -9.17, a price-to-earnings-growth ratio of 1.74 and a beta of 0.96.

Hedge Funds Weigh In On DENTSPLY SIRONA

Several hedge funds have recently added to or reduced their stakes in XRAY. Nordea Investment Management AB lifted its position in shares of DENTSPLY SIRONA by 245.0% during the 4th quarter. Nordea Investment Management AB now owns 251,556 shares of the medical instruments supplier’s stock worth $4,754,000 after buying an additional 178,639 shares during the last quarter. JPMorgan Chase & Co. lifted its position in DENTSPLY SIRONA by 206.3% in the third quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier’s stock valued at $49,990,000 after acquiring an additional 1,244,326 shares during the last quarter. Barclays PLC boosted its stake in DENTSPLY SIRONA by 21.8% in the third quarter. Barclays PLC now owns 306,809 shares of the medical instruments supplier’s stock valued at $8,301,000 after acquiring an additional 54,920 shares in the last quarter. Canvas Wealth Advisors LLC grew its holdings in shares of DENTSPLY SIRONA by 126.5% during the fourth quarter. Canvas Wealth Advisors LLC now owns 326,298 shares of the medical instruments supplier’s stock worth $6,245,000 after purchasing an additional 182,234 shares during the last quarter. Finally, Quantinno Capital Management LP increased its position in shares of DENTSPLY SIRONA by 276.5% during the third quarter. Quantinno Capital Management LP now owns 116,808 shares of the medical instruments supplier’s stock worth $3,161,000 after purchasing an additional 85,787 shares in the last quarter. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.